Science
Mechanism of Action
Ethylhexyl Methoxycinnamate (Octinoxate) functions by absorbing harmful UVB radiation, particularly within the 280-320 nm range with peak protection at 310 nm, preventing its penetration into the skin. This absorbed UV energy is then converted into a benign form, primarily heat, offering protection against sunburn and age-related changes caused by UVB exposure. It exclusively targets UVB rays, without significant UVA protection.
Research
Clinical Evidence
High confidenceN/A
Key findings
- 01 The FDA in the United States approves Ethylhexyl Methoxycinnamate for use as a sunscreen active ingredient up to a maximum concentration of 7.5%.
- 02 The SCCS in the European Union, in its June 30, 2025 opinion, concluded Ethylhexyl Methoxycinnamate is safe for use as a UV filter up to a maximum concentration of 10% in various cosmetic products, including for children.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Ethylhexyl Methoxycinnamate exhibits photolability, with approximately 10% SPF protection loss within 35 minutes of sun exposure due to degradation. It can also generate free radicals if not adequately stabilized. Its photostability and overall efficacy are significantly enhanced through co-formulation with other sunscreen agents like Octocrylene or antioxidants, which also help provide broad-spectrum protection. A high polarity in the oil phase and a higher concentration of EHMC contribute to improved photostability. As a cinnamic acid derivative, it is light-sensitive, necessitating the addition of antioxidants to formulations. It is chemically stable under standard ambient conditions.
Synergies
- Octocrylene (for photostability and broad-spectrum protection)
- Antioxidants (to prevent free radical generation and enhance stability)
Safety
Safety Profile
Ethylhexyl Methoxycinnamate is approved by the FDA up to 7.5% in the US and deemed safe by the SCCS up to 10% in the EU, including for children. The SCCS's June 2025 conclusion acknowledged its endocrine-active properties (estrogenic and weak anti-androgenic activity) based on in vitro and in vivo evidence, yet confirmed its safety within approved concentrations. Earlier assessments included a preliminary SCCS opinion (Oct 2024) indicating insufficient data to rule out genotoxicity, and a 2015 CIR Expert Panel finding data insufficient for leave-on formulations, which have since been superseded by the more recent SCCS opinion.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Ethylhexyl Methoxycinnamate is a valuable UVB filter with widespread regulatory approval, effectively protecting against sunburn and photoaging, though careful formulation with stabilizers is essential to maintain its photostability and efficacy.
Related
Similar Ingredients
Finding similar ingredients…